Dialling up the asset management products in China
New regulatory guidelines in China for insurers' asset management products could electrify the once contentious $400bn market. David Walker reports
New regulatory guidelines in China for insurers' asset management products could electrify the once contentious $400bn market. David Walker reports
Stuart Jarvis looks at how reporting rules have developed and why they are tightening, and how insurers can approach investment decisions in the new ALM landscape.
.jpg)
Based on their experience with a joint insurance clients, JP Morgan Asset Management and Clearwater Analytics discuss the ins and outs of implementing the accounting standard, and why insurers should start early. Interview by Vincent Huck
Investment markets look for brighter days even while the gloomiest persist. Some insurers' chief investment officers are doing the same, as David Walker reports
As some insurers follow suit on regulators' urge not to pay dividends and others refuse to comply, Vincent Huck looks at whether dividend retention could result in more ammunition for the investment teams to invest in markets
.jpg)
Sarfraz Thind takes a deep dive into how Covid-19 has distorted the market. In part one of this two part series he looks at commercial mortgage-backed securitisations (CMBS), collateralised loan obligation (CLO) and municipal bonds.
Insurance Asset Risk surveyed the industry to find out how it is rethinking asset allocation in the wake of COVID-19's impact on the economy and financial markets. Vincent Huck presents the results
Frank Schiller, board member of the DAV, tells David Walker in a far ranging interview his thoughts on the 2020 Solvency II review and where he believes EIOPA needs to step up its work.
.jpg)
As European regulators offer some leeway on Solvency II regulatory reporting deadlines, insurers seem inclined to follow the original schedule. Begging the question of how to account for the COVID-19 impact. David Walker reports
Could European underwriters have a thing or two to learn from their Chinese counterparts when it comes to transparency in their reporting? David Walker takes a closer look
With lower ratings than their developed market counterparts and potential economic dependencies to oil, emerging markets are on the frontline of the COVID-19 crisis. It is raising questions for insurers' allocation to the asset class. Vincent Huck reports
Jegor Tokarevich and Amirlan Seksenbayev from Substance Over Form, look at the risks posed by COVID-19 to insurance investors and how they can mitigate them to make the most of the opportunities arising.